PDB20 LONG-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR COMPARED TO NEUTRAL PROTAMINE HAGEDORN INSULIN IN PATIENTS WITH TYPE 1 DIABETES USING A BASAL-BOLUS REGIMEN IN BELGIUM, FRANCE, GERMANY, ITALY AND SPAIN

Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden

Scandinavian Journal of Public Health ◽

10.1177/1403494810379290 ◽

2010 ◽

Vol 39 (1) ◽

pp. 79-87 ◽

Cited By ~ 16

Author(s):

William J. Valentine ◽

Mark Aagren ◽

Mattias Haglund ◽

Åsa Ericsson ◽

Manuela H. Gschwend

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Detemir ◽

PDB68 LONG-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR COMPARED TO NEUTRAL PROTAMINE HAGEDORN INSULIN IN PATIENTS WITH TYPE 1 DIABETES USING A BASAL-BOLUS REGIMEN IN SWEDEN

Value in Health ◽

10.1016/s1098-3015(10)66672-7 ◽

2008 ◽

Vol 11 (6) ◽

pp. A503

Author(s):

WJ Valentine ◽

M Lammert ◽

M Aagren ◽

MH Gschwend

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Detemir ◽

Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries

Journal of Medical Economics ◽

10.3111/13696990903080344 ◽

2009 ◽

Vol 12 (2) ◽

pp. 114-123 ◽

Cited By ~ 16

Author(s):

Manuela Helena Gschwend ◽

Mark Aagren ◽

William J Valentine

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Detemir ◽

European Countries ◽

PDB28 COST-EFFECTIVENESS ANALYSES OF BASAL-BOLUS THERAPY OF TYPE-1 DIABETES USING INSULIN DETEMIR + HUMAN SOLUBLE INSULIN VERSUS NEUTRAL PROTAMINE HAGEDORM + HUMAN SOLUBLE INSULIN REGIMENS IN GERMANY

Value in Health ◽

10.1016/s1098-3015(10)67647-4 ◽

2005 ◽

Vol 8 (6) ◽

pp. A163

Author(s):

WJ Valentine ◽

AJ Palmer ◽

KU Wittrup-Jensen ◽

S Roze

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Detemir ◽

Soluble Insulin ◽

DB6 COMPARISON OF THE COST-EFFECTIVENESS FOR BASAL-BOLUS THERAPY OF TYPE-1 DIABETES USING INSULIN DETEMIR+ INSULIN ASPART OR HUMAN INSULIN-BASED REGIMENS IN THE NETHERLANDS

Value in Health ◽

10.1016/s1098-3015(10)62626-5 ◽

2005 ◽

Vol 8 (3) ◽

pp. 255

Author(s):

Valentine Wj ◽

K Wittrup-Jensen ◽

AJ Palmer ◽

S Roze

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

The Netherlands ◽

Human Insulin ◽

Insulin Aspart ◽

Insulin Detemir ◽

The Cost ◽

Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 1 Diabetes Mellitus In Spain

Value in Health ◽

10.1016/j.jval.2014.08.687 ◽

2014 ◽

Vol 17 (7) ◽

pp. A343 ◽

Cited By ~ 1

Author(s):

de Arellano A. Ramírez ◽

L. Lizán ◽

M. Prades ◽

C. Morales ◽

Luis D. De

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

Type 1 Diabetes Mellitus ◽

Insulin Detemir ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Neutral Protamine Hagedorn

Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal–bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial

Diabetic Medicine ◽

10.1111/j.1464-5491.2007.02407.x ◽

2008 ◽

Vol 25 (4) ◽

pp. 442-449 ◽

Cited By ~ 102

Author(s):

P. C. Bartley ◽

M. Bogoev ◽

J. Larsen ◽

A. Philotheou

Keyword(s):

Randomized Controlled Trial ◽

Insulin Detemir ◽

Controlled Trial ◽

Treat To Target ◽

Efficacy And Safety ◽

Randomized Controlled ◽

PDB21 COST-EFFECTIVENESS ANALYSIS OF BASAL/BOLUS THERAPY IN TYPE-1 DIABETES USING INSULIN DETEMIR + INSULIN ASPART OR HUMAN SOLUBLE INSULIN-BASED BASAL/BOLUS REGIMENS IN GERMANY

Value in Health ◽

10.1016/s1098-3015(10)67640-1 ◽

2005 ◽

Vol 8 (6) ◽

pp. A160-A161

Author(s):

WJ Valentine ◽

KU Wittrup-Jensen ◽

AJ Palmer ◽

S Roze

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Aspart ◽

Insulin Detemir ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Soluble Insulin ◽

PDB1 THE IMPACT OF INSULIN DETEMIR COMPARED TO NEUTRAL PROTAMINE HAGEDORN INSULIN ON LONG-TERM DIABETES-RELATED COMPLICATIONS: A MODELING ANALYSIS IN TYPE 1 DIABETES PATIENTS IN BELGIUM, FRANCE, GERMANY, ITALY AND SPAIN

Value in Health ◽

10.1016/s1098-3015(10)66648-x ◽

2008 ◽

Vol 11 (6) ◽

pp. A495

Author(s):

MH Gschwend ◽

M Aagren ◽

WJ Valentine

Keyword(s):

Type 1 Diabetes ◽

Insulin Detemir ◽

Modeling Analysis ◽

The Impact ◽

Diabetes Patients

Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United Kingdom

Value in Health ◽

10.1016/j.jval.2013.08.685 ◽

2013 ◽

Vol 16 (7) ◽

pp. A442

Author(s):

B. Chubb ◽

M. Evans ◽

M. Wolden ◽

T. Christensen ◽

J. Gundgaard

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Insulin Degludec ◽

The United Kingdom ◽